Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navarixin in Neutrophilic Asthma
NCT00632502Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of navarixin in neutrophilic asthma, sponsored by Merck & Co.. Started May 2008; status: completed.
02
Drugs
navarixin
03
Conditions
neutrophilic asthma
Beyond the preview
Go deeper on NCT00632502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00632502.